Your Privacy and our use of cookies

Cookies help us improve your ABPI online experience. If you accept their use, continue using our site. or, find out more about cookies.

  • I agree. Continue using site.
  • No. Take me to settings.
  • Skip to content
  • ABPI Logo
    • About the ABPI
      Arrow Icon

      Back

      • About the ABPI
        • ABPI Board
        • ABPI Leadership team
        • ABPI Cymru Wales
        • ABPI Northern Ireland
        • ABPI Scotland
        • Jobs at the ABPI
        • News
        • Blogs
        • Publications
      • Woman holding a large Ukraine flag close to her face

        Ukraine - UK Pharmaceutical Industry Response

        We stand in solidarity with the people of Ukraine and condemn the invasion of their country. As an industry dedicated to saving lives, we stand for peace.

      • ABPI Code of Practice open on a green background

        ABPI 2021 Code of Practice

        The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.

    • Our focus
      Arrow Icon

      Back

      • INTERNATIONAL, TRADE AND IP
        • International Research
        • Intellectual property (IP)
        • International trade
        • International regulation
      • WORKING IN PARTNERSHIP
        • Working with the NHS
        • NHS-Industry Partnership Case Studies Repository
        • ABPI Patient Advisory Council
        • Working with patient organisations
      • VALUING AND ACCESSING MEDICINES
        • UK medicine pricing
        • Advanced Therapy Medicinal Products (ATMPs)
        • NICE methods and process evolution
        • Regulatory science
        • Appropriate prescribing
        • Medicine supply
        • Vaccines
      • RESEARCH, DEVELOPMENT AND MANUFACTURING
        • Building a thriving environment for medicine discovery
        • Manufacturing
        • Regulatory science
        • Clinical research
        • Genomics in healthcare and research
        • Drug safety - pharmacovigilance
        • Research using animals
      • INDUSTRY REPUTATION
        • ABPI Code of Practice
        • Disclosure UK
        • ABPI Medical Representatives Exam
        • ABPI’s Equality, Diversity and Inclusion Strategy
        • Valuing Vaccines
        • UK Pharma Reputation Index
        • Sustainability
      • HEALTH DATA
        • ABPI health data principles
        • Health data and new medicines
        • Building trust in health data use
        • Harnessing the opportunities
        • Enhancing the UK health data environment
      • CONTENT HUBS
        • COVID-19
        • Rare diseases
        • Antimicrobial resistance
        • Ukraine
    • Membership
      Arrow Icon

      Back

      • ABPI membership
        • Events
        • ABPI Members list
        • Become an ABPI member
      • Members

        Membership

        We represent our members, using their insight and experience to tell the story of how they change the lives of millions of people every day.

      • PMCPA | launch of social media guidance

        PMCPA | launch of social media guidance

        PLEASE NOTE THIS WEBINAR IS NOW FULL. The Prescription Medicines Code of Practice Authority (PMCPA) has published new social media guidance to help pharmaceutical companies apply the high standards demanded by the industry’s Code of Practice to all their online communications channels.

    • Our industry
      Arrow Icon

      Back

      • Facts, figures and industry data
        • UK pharmaceutical market
        • Global pharmaceutical market
        • Cancer in the UK - Digital Data Toolkit
        • Clinical trials
        • Medicine discovery - facts and figures
      • Industry-Academic Links Survey 2022
        • Apprenticeships
        • Undergraduate industrial placements
        • Graduate placement & recruitment
        • PhD Collaborations & Studentships
        • Postdoctoral researchers
        • Other
      • Careers
        • ABPI exam
        • Why work in the industry
        • Pharmaceutical recruiters
        • Working in the industry
        • Job roles and case studies
        • International (non-EU) applicants
        • School & college studies
        • Undergraduates
        • Post-graduates & post-doctoral researchers
        • Medical practitioners
      • Case Studies
        • Scientist with vial Analytical Chemist
        • View looking up at a scientist using a pipette Analytical Chemist (Discovery)
    • Media
      Arrow Icon

      Back

    • Resources for schools
  • Search Icon
  • Menu Icon
  • Resources for schools
  • ABPI Website
  • Ensuring value, access & uptake of innovative medicines & vaccines, now & in the future
  • UK medicine pricing
UK medicine pricing
Medicine development

title-strip icon Medicine development

Medicines and vaccines are some of the most important ways we have to fight disease on a global scale and keep people fit and healthy.

Medicine pricing

title-strip icon Medicine pricing

The UK has robust measures in place to ensure that medicines and vaccines are both clinically and cost effective before they can be used in the NHS.

Voluntary Scheme on branded medicines

title-strip icon Voluntary Scheme on branded medicines

The new 2019 Voluntary Scheme ‘VPAS’ is a commitment by industry, the NHS and Government to support innovation for the benefit of patients across the UK. 

Medicine lifecycle

title-strip icon Medicine lifecycle

Once a new medicine is no longer covered by a patent it can be manufactured by any company around the world. 

Improving access to medicines in the UK

title-strip icon Improving access to medicines in the UK

The UK is a world leader in pharmaceutical research and development, and it is vital that NHS patients are able to access the latest treatments as fast as patients in other countries.

Future of medicine

title-strip icon Future of medicine

With 7,000 medicines and vaccines in the global pipeline, the future of health looks exciting. The pharmaceutical industry is pioneering new treatments and new technologies that will change the face of modern medicine. 

Innovating medicines funding in Scotland

title-strip icon Innovating medicines funding in Scotland

Scotland receives superb value from the latest medicines and vaccines thanks to robust measures which ensure NHS Scotland uses treatments that are both cost and clinically effective.

What was the PPRS?

title-strip icon What was the PPRS?

The UK has a number of different mechanisms for ensuring value for money and cost control in the NHS. In addition to NICE which evaluates cost-effectiveness, the Pharmaceutical Pricing Regulation Scheme (PPRS) helps controls the amount the NHS spends on new medicines.

Close-up of the hands of two office workers writing notes on a desk between to open laptops

title-strip icon NHS medicine spend

The UK has robust measures in place to ensure that medicines and vaccines are both clinically and cost-effective before they can be used in the NHS.

ABPI Logo

The Association of the British Pharmaceutical Industry is a company Limited by guarantee registered in England and Wales (registered number 09826787).

2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Telephone +44 (0) 2079303477

ABPI 2023

 

 


Find out more about our commitment to providing trustworthy health information.

  • Twitter
  • LinkedIn
  • YouTube
USEFUL LINKS
  • Contact us
  • Careers
  • ABPI Exam
  • ABPI Schools
WEBSITE INFO
  • Terms & conditions
  • Accessibility
  • Cookie policy